Lifera and CENTOGENE, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing
- Sunday, July 2, 2023, 7:02
- Finance
- Add a comment
Joint Venture (JV) combines CENTOGENE’s global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly owned by the Public Investment Fund (PIF) based in Riyadh. JV focuses on providing state-of-the-art multiomic testing services to patients, health…